Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 13 citing articles:

PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells
Zahra Nasrpour Navaei, Ghazaleh Khalili‐Tanha, Amir Sadra Zangouei, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2021) Vol. 29, Iss. 4, pp. 235-250
Open Access | Times Cited: 42
Unraveling the role of deubiquitinating enzymes on cisplatin resistance in several cancers
S. Jin, Kwang‐Hyun Baek
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189297-189297
Closed Access
Epilepsy-Related CDKL5 Deficiency Slows Synaptic Vesicle Endocytosis in Central Nerve Terminals
Christiana Kontaxi, Daniela Ivanova, Elizabeth C. Davenport, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 11, pp. 2002-2020
Open Access | Times Cited: 14
CMGC Kinases in Health and Cancer
Iftekhar Chowdhury, Giovanna Dashi, Salla Keskitalo
Cancers (2023) Vol. 15, Iss. 15, pp. 3838-3838
Open Access | Times Cited: 11
LINC00680 modulates docetaxel resistance in breast cancer via the miR-320b/CDKL5 axis
Jia Li, Jing Ke, Chenglin Qin, et al.
International Journal of Immunopathology and Pharmacology (2022) Vol. 36
Open Access | Times Cited: 9
A review of CDKL: An underestimated protein kinase family
Chenrui Li, Yan Liu, Shilu Luo, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 133604-133604
Open Access | Times Cited: 1
CDKL3 Promotes Non-small Cell Lung Cancer by Suppressing Autophagy Via Activation of PI3K/Akt/mTOR Pathway
Rong Li, Linyan Chai, Lei Lei, et al.
Molecular Biotechnology (2023) Vol. 65, Iss. 9, pp. 1421-1431
Closed Access | Times Cited: 4
Gene expression profiling of the spinal cord at the chronic pain phase identified CDKL5 as a candidate gene for neural remodeling
Takashi Hozumi, Setsu Sawai, Tatsuya Jitsuishi, et al.
Neuroscience Letters (2021) Vol. 749, pp. 135772-135772
Closed Access | Times Cited: 10
Epilepsy-related CDKL5 deficiency slows synaptic vesicle endocytosis in central nerve terminals
Christiana Kontaxi, Elizabeth C. Davenport, Peter C. Kind, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
The role of KDM4A‐mediated histone methylation on temozolomide resistance in glioma cells through the HUWE1/ROCK2 axis
Xi-xi Li, Jia‐Kun Xu, Weijie Su, et al.
The Kaohsiung Journal of Medical Sciences (2023) Vol. 40, Iss. 2, pp. 161-174
Open Access | Times Cited: 2
ELK1-CDKL5-Rac1 signaling pathway regulates the migration of endothelial cells to promote angiogenesis induced by nanoniobium particles
Xiaohe Zhou, Minhua Mo, Zi-Wei Chen, et al.
Rare Metals (2024)
Closed Access
Epigentic Regulators of Glioma Stem Cells are Potential Therapeutic Targets
Muhammad Babar Khan, Júlia Schneider, Kevin Kwan, et al.
Neurosurgery (2018) Vol. 82, Iss. 5, pp. E104-E105
Open Access | Times Cited: 4
Protein Kinase A–Mediated Effects of Protein Kinase C Partial Agonist 5-(Hydroxymethyl)Isophthalate 1a3 in Colorectal Cancer Cells
Ilari Tarvainen, Rebecca Nunn, Raimo K. Tuominen, et al.
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 380, Iss. 1, pp. 54-62
Open Access | Times Cited: 3
LINC00680 Modulates Docetaxel Resistance in Breast Cancer via miR-320b/CDKL5 Axis
Jia Li, Ke Jin, Chenglin Qin, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 1
Page 1

Scroll to top